Metabolomics: Discovery of metabolite biomarkers and Discovery of peptide biomarkers; SRM/MRM method development
Immunoproteomics: Discovery of MHC peptide antigens in Cancer
Proteomics : Glycoprotein biomarkers and Post-translational modificatins ; Characterization of antibodies and antibody drug conjugates
Ovarian Cancer: Altered metabolic pathways, drug-ressitance and omics